Abstract
Despite adequate sample size and high enrollment of patients with confirmed gram-negative sepsis, E5 did not improve short-term survival. Current study rationale and designs should be carefully reviewed before further large-scale studies of patients with sepsis are conducted.
Keywords
MedicinePlaceboInterim analysisSepsisSeptic shockClinical endpointRandomized controlled trialAdverse effectInternal medicineShock (circulatory)Relative riskConfidence interval
Affiliated Institutions
Related Publications
Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin
HA-1A is safe and effective for the treatment of patients with sepsis and gram-negative bacteremia.
Trial of Early, Goal-Directed Resuscitation for Septic Shock
In patients with septic shock who were identified early and received intravenous antibiotics and adequate fluid resuscitation, hemodynamic management according to a strict EGDT ...
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
INTRODUCTION Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection (1). Sepsis and septic shock are major healthcare problems, impacti...
High versus Low Blood-Pressure Target in Patients with Septic Shock
Targeting a mean arterial pressure of 80 to 85 mm Hg, as compared with 65 to 70 mm Hg, in patients with septic shock undergoing resuscitation did not result in significant diffe...
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
Publication Info
- Year
- 2000
- Type
- article
- Volume
- 283
- Issue
- 13
- Pages
- 1723-1723
- Citations
- 261
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
261
OpenAlex
Cite This
Derek C. Angus
(2000).
E5 Murine Monoclonal Antiendotoxin Antibody in Gram-Negative Sepsis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>.
JAMA
, 283
(13)
, 1723-1723.
https://doi.org/10.1001/jama.283.13.1723
Identifiers
- DOI
- 10.1001/jama.283.13.1723